Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 286 AL 300

Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis

Liu D, Cao B, Zhao Y, Huang H, McIntyre RS, Rosenblat JD, Zhou H.

Neurosci Lett. 2018 Nov 1;686:10-16. doi: 10.1016/j.neulet.2018.08.038. Epub 2018 Aug 29.

Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment

Dos Santos Picanco LC, Ozela PF, de Fatima de Brito Brito M, Pinheiro AA, Padilha EC, Braga FS, de Paula da Silva CHT, Dos Santos CBR, Rosa JMC, da Silva Hage-Melim LI.

Curr Med Chem. 2018;25(26):3141-3159. doi: 10.2174/0929867323666161213101126.

A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease

O'Bryant SE, Zhang F, Johnson LA, Hall J, Edwards M, Grammas P, Oh E, Lyketsos CG, Rissman RA.

J Alzheimers Dis. 2018;66(1):97-104. doi: 10.3233/JAD-180619.

The Gut-Brain Axis in Alzheimer's Disease and Omega-3. A Critical Overview of Clinical Trials

La Rosa F, Clerici M, Ratto D, Occhinegro A, Licito A, Romeo M, Iorio CD, Rossi P.

Nutrients. 2018 Sep 8;10(9):1267. doi: 10.3390/nu10091267.

The effect of physical exercise on cerebral blood flow in Alzheimer's disease

van der Kleij LA, Petersen ET, Siebner HR, Hendrikse J, Frederiksen KS, Sobol NA, Hasselbalch SG, Garde E.

Neuroimage Clin. 2018 Sep 4;20:650-654. doi: 10.1016/j.nicl.2018.09.003. eCollection 2018.

Reducing disability via a family centered intervention for acutely ill persons with Alzheimer's disease and related dementias: protocol of a cluster-randomized controlled trial (Fam-FFC study)

Boltz M, Kuzmik A, Resnick B, Trotta R, Mogle J, BeLue R, Leslie D, Galvin JE.

Trials. 2018 Sep 17;19(1):496. doi: 10.1186/s13063-018-2875-1.

Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer's disease (BLAZE)

Salloway S, Honigberg LA, Cho W, Ward M, Friesenhahn M, Brunstein F, Quartino A, Clayton D, Mortensen D, Bittner T, Ho C, Rabe C, Schauer SP, Wildsmith KR, Fuji RN, Suliman S, Reiman EM, Chen K, Paul R.

Alzheimers Res Ther. 2018 Sep 19;10(1):96. doi: 10.1186/s13195-018-0424-5.

Physical activity can improve cognition in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Du Z, Li Y, Li J, Zhou C, Li F, Yang X.

Clin Interv Aging. 2018 Sep 4;13:1593-1603. doi: 10.2147/CIA.S169565. eCollection 2018.

Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study

Nagata T, Shinagawa S, Nakajima S, Mimura M, Shigeta M.

J Alzheimers Dis. 2018;66(1):139-148. doi: 10.3233/JAD-180304.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.

PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.

Alzheimer's Disease: Special Focus on the Efficacy of Computer-Based Training Programs - A Mini-Review

Klimova B, Kuca K, Maresova P.

Curr Alzheimer Res. 2018;15(13):1213-1219. doi: 10.2174/1567205015666180925105902.

Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition

Grizzanti J, Corrigan R, Casadesus G.

J Alzheimers Dis. 2018;66(1):11-23. doi: 10.3233/JAD-180433.

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

Hampel H, O'Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S, Kiddle SJ, Batrla R, Blennow K.

Nat Rev Neurol. 2018 Nov;14(11):639-652. doi: 10.1038/s41582-018-0079-7.

Coping strategies among caregivers of people with Alzheimer disease: a systematic review

Monteiro AMF, Santos RL, Kimura N, Baptista MAT, Dourado MCN.

Trends Psychiatry Psychother. 2018 Jul-Sep;40(3):258-268. doi: 10.1590/2237-6089-2017-0065.

Alzheimer's Disease, time to turn the tide

Sensi SL.

Aging (Albany NY). 2018 Oct 13;10(10):2537-2538. doi: 10.18632/aging.101581.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias